Add to ORKGThis research investigated a method to predict medicinal potential of plants. The study used Australasian magnoliids, to identify chemical similarity among evolutionary related plants. Findings pointed that several related plants shared similar medicinal metabolites. Therefore evolutionary history and chemical similarity could be used to predict plant medicinal potential
Introduction: Propolis, a sticky substance produced by bees from plant resins, has a long history of...
Ethnobotanical-directed bioprospecting has made a significant contribution to modern drug discoverie...
Eukaryotes such as higher plants have evolved to produce a diverse range of low-molecular-weight com...
Plants have been a source of medicines in human cultures for millennia. The past decade has seen a d...
In response to the environment, plants produce a phytochemical arsenal to communicate and to withsta...
The number of new drugs coming to the market is declining while interest in lead discovery from natu...
Secondary metabolites are important mediators of a variety of biotic and abiotic interactions betwee...
The current decrease of new drugs brought to the market has fostered renewed interest in plant-based...
Biological diversity is evidence for chemical diversity. Secondary metabolites are adaptive traits, ...
Specialized compounds from photosynthetic organisms serve as rich resources for drug development. Fr...
Eremophila is the largest genus in the plant tribe Myoporeae (Scrophulariaceae) and exhibits incredi...
Background: Natural products (NP) from plants and microbes are a rich source for bioactive compounds...
Plants naturally produce a terrific diversity of molecules, which we exploit for promoting our overa...
Covering: Up to 2019 Phylogenetic methods become increasingly important in natural product research....
Plant derived medicine is an important source of life saving drugs, but the genome information of mo...
Introduction: Propolis, a sticky substance produced by bees from plant resins, has a long history of...
Ethnobotanical-directed bioprospecting has made a significant contribution to modern drug discoverie...
Eukaryotes such as higher plants have evolved to produce a diverse range of low-molecular-weight com...
Plants have been a source of medicines in human cultures for millennia. The past decade has seen a d...
In response to the environment, plants produce a phytochemical arsenal to communicate and to withsta...
The number of new drugs coming to the market is declining while interest in lead discovery from natu...
Secondary metabolites are important mediators of a variety of biotic and abiotic interactions betwee...
The current decrease of new drugs brought to the market has fostered renewed interest in plant-based...
Biological diversity is evidence for chemical diversity. Secondary metabolites are adaptive traits, ...
Specialized compounds from photosynthetic organisms serve as rich resources for drug development. Fr...
Eremophila is the largest genus in the plant tribe Myoporeae (Scrophulariaceae) and exhibits incredi...
Background: Natural products (NP) from plants and microbes are a rich source for bioactive compounds...
Plants naturally produce a terrific diversity of molecules, which we exploit for promoting our overa...
Covering: Up to 2019 Phylogenetic methods become increasingly important in natural product research....
Plant derived medicine is an important source of life saving drugs, but the genome information of mo...
Introduction: Propolis, a sticky substance produced by bees from plant resins, has a long history of...
Ethnobotanical-directed bioprospecting has made a significant contribution to modern drug discoverie...
Eukaryotes such as higher plants have evolved to produce a diverse range of low-molecular-weight com...